MANNINO RAPHAEL J 4
4 · Matinas BioPharma Holdings, Inc. · Filed Jun 24, 2020
Insider Transaction Report
Form 4
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
- Other
Common Stock, par value $0.0001 per share
2020-06-23+3,000→ 1,429,565 total
Footnotes (1)
- [F1]Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock.